Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Bioventus Inc. (BVS) had Debt to Capital Ratio of 0.62 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$123.88M |
|
$-2.64M |
|
$40.82M |
|
$83.06M |
|
$119.01M |
|
$4.87M |
|
$-8.29M |
|
$-3.42M |
|
$-3.42M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$4.87M |
|
$16.73M |
|
66.01M |
|
66.01M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$249.37M |
|
$25.72M |
|
$442.05M |
|
$691.41M |
|
$174.75M |
|
$308.59M |
|
$331.18M |
|
$505.94M |
|
$185.48M |
|
$-217.71M |
|
$185.48M |
|
82.02M |
|
| Cash Flow Statement Financials | |
$-19.33M |
|
$-0.83M |
|
$0.95M |
|
$41.58M |
|
$22.80M |
|
$-18.78M |
|
$2.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.43 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.62 |
1.87 |
|
67.05% |
|
3.93% |
|
3.93% |
|
-- |
|
-2.76% |
|
-2.13% |
|
$-20.16M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.43 |
|
1.05 |
|
85.79 |
|
-1.79% |
|
1.53% |
|
-0.48% |
|
-0.67% |
|
$2.26 |
|
$-0.31 |
|
$-0.29 |
|